Market Research Logo

Drug Delivery Series: The Market for Transdermal and Transmucosal Drug Delivery Systems: Volume 4

Drug Delivery Series: The Market for Transdermal and Transmucosal Drug Delivery Systems: Volume 4

This volume will address transdermal and transmucosal drug delivery systems. Both of these systems continue to be of high interest for the delivery of proteins and peptides due to high permeability of mucosal tissue and adaptability of dermal application.


The Drug Delivery Series

An Innovative NEW Series of Five Reports, Featuring Primary Research & Global Coverage

Drug delivery is one of the most important drivers in the rapidly changing pharmaceutical industry. Each volume of this new series examines an area of drug delivery singly and in depth. Market opportunities, new technologies and products, shifting alliances and licensing deals, important trends, and forecasts through 2005 are covered in each of the five volumes of the series.

Kalorama’s analysts have taken a unique look at the market today and in the future by calculating not only total market size and growth, but also the relative value of the drug delivery component itself as separate from total pharmaceutical sales. This quantitative analysis is extremely instructive and unique to this series of reports.

Anyone involved in the pharmaceutical industry—drug delivery companies or pharmaceutical manufacturers—can turn to this series to examine competitors, extend product life cycles, and learn more about the plethora of advanced drug delivery systems in development that will suit currently available products.

For each of the major delivery routes, the series covers:

  • Market size, segmentation, and growth
  • Market drivers, barriers, and trends
  • Competitive analysis of companies and products—both current and in development
  • Value of drug delivery technology in relation to pharmaceutical products
  • Impact of delivery technology on the viability of new biopharmaceuticals
  • Implications for pharmaceutical sales and marketing
  • Profiles of the major players, including partnerships and alliances
  • International directory of companies involved in the segment

Use These Valuable Reports to:

  • Define and size your target market
  • Capitalize on industry trends
  • Reduce the risk of your business investment
  • Position yourself against your competition
  • Effectively launch new products or enter new markets
  • Create successful marketing and sales strategies
  • Create highly-targeted marketing messages
  • Strengthen brand awareness
  • Identify new revenue opportunities
  • Empower your sales force with the tools they need to succeed

Scope and Methodology

The market for transdermal/transmucosal drug delivery systems details the types of drug delivery systems and technologies that are being used in 2000, as well as those that may become major market factors by the end of the forecast period. The report describes the industry, its relationship to various healthcare channels, and the trends for the future.

The transdermal/transmucosal drug delivery market is two-fold. First of all, it encompasses drug delivery technology and the revenues earned from licensing that technology. Secondly, it encompasses the pharmaceutical arena as well. Because drug delivery technology is an integral part of sales of pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that include pharmaceutical sales. This is inclusive of the entire market for transdermal/transmucosal drug delivery. This report will provide market data that include the pharmaceutical and drug delivery revenues in total; but also, it will demonstrate the percent of revenues that are attributed solely to drug delivery sales. This will be presented for the entire forecast period from 1996 to 2006.

Chapter 1: Executive Summary


    Market Drivers
    Market Size and Growth
    • Total Transdermal/Transmucosal Drug Delivery Market
    • Transdermal/Transmucosal Drug Delivery Only Market

    Competitive and Market Analysis

Chapter 2: Introduction and Overview


    Scope and Methodology
    Reasons for Transdermal/Transmucosal Drug Delivery Systems
    History of Transdermal and Transmucosal Drug Delivery
    Phases of Drug Action
    Topical Drug Delivery
    • Types of Topics Preparations
    • Market Participants

    Transdermal Patch Drug Delivery
    • Membrane-Controlled System
    • Adhesive Dispersion-Type System,
    • Matrix Diffusion-Controlled System
    • Microreservior Dissolution-Controlled System
    • Market Participants

    Electrotransport Drug Delivery
    Iontophoresis
    Transmucosal Drug Delivery
    • Oral Transmucosal Fentanyl Citrate (OTFC)
    • Transmucosal Etomidate
    • Ondansetron ODT

    Buccal Drug Delivery
    Vaginal Drug Delivery

Chapter 3: Trends and Developments


    Adhesive Technology and Issues
    Adhesive Market Issues
    Biotechnological Issues
    Iontophoresis and Phonophoresis
    Developments in Insulin Delivery
    New Developments in Hormone Drug Delivery
    New Mucosal/Buccal Delivery Systems
    Other New Drug Delivery Systems
    Macroflux Technology
    Controlled Thermal Energy Technology
    New Ultrasound Technology
    Combination Delivery Technology

Chapter 4: Market Size and Growth

Chapter 5: Competitive Analysis


    Competitive Landscape
    Market Analysis

Chapter 6: Company Profiles


    3M Pharmaceuticals
    Alza Corporation
    Elan Corporation, plc
    Generex Biotechnology Corporation
    Genetronics Biomedical Corporation
    Labtec GmbH
    Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
    MacroChem Corporation
    Noven Pharmaceuticals, Inc.
    TheraTech, Inc. (Watson Laboratories, Utah)

Chapter 7: Companies in Brief


    Altea Development Corp.
    Anteres Pharma, Inc.
    Atrix Laboratories, Inc.
    Biogel Technology, Inc.
    CeNeS Drug Delivery Ltd.
    SkyePharma Plc
    TransDermal Technologies, Inc.
    Vyteris Inc.

Appendix: Company Directory

List of Exhibits


    Table 2-1: Sequence of Drug Action
    Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Type, 1995-2005
    Table 4-2: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Market Percent Share by Type, 1995-2005
    Table 4-3: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 1995-2005
    Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
    Table 5-1: Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Revenues and Market Share by Supplier, 2000
    Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Revenues by Type, 1995-2005
    Figure 4-2: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Share by Type, 2000
    Figure 4-3: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Share by Type, 2005
    Figure 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
    Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2000
    Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2005
    Figure 5-1: Worldwide Market for Pulmonary Drug Delivery Systems, Market Share by Leading Supplier, 2000

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report